




已閱讀5頁,還剩38頁未讀, 繼續(xù)免費(fèi)閱讀
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
MitchellHOROWitz CardiopulmonaryExerciseTesting Outline DescriptionofCPETWhoshouldandwhoshouldnotgetCPETWhentoterminateCPETExercisephysiologyDefineterms respiratoryexchangeratio ventilatoryequivalent heartratereserve breathingreserve oxygenpulsePatternofCPETresultsCOPDvsCHF RationaleforExerciseTesting Cardiopulmonarymeasurementsobtainedatrestmaynotestimatefunctionalcapacityreliably ClinicalExerciseTests 6 minwalktestSubmaximalShuttlewalktestIncremental maximal symptom limitedExercisebronchoprovocationExertionaloximetryCardiacstresstestCPET KarlmanWasserman CouplingofExternalVentilationandCellularMetabolism AdaptationsofWasserman sGears GeneralMechanismsofExerciseLimitation PulmonaryVentilatoryRespiratorymuscledysfunctionImpairedgasexchangeCardiovascularReducedstrokevolumeAbnormalHRresponseCirculatoryabnormalityBloodabnormality PeripheralInactivityAtrophyNeuromusculardysfunctionReducedoxidativecapacityofskeletalmuscleMalnutritionPerceptualMotivationalEnvironmental WhatisCPET Symptom limitedexercisetestMeasureairflow SpO2 andexpiredoxygenandcarbondioxideAllowscalculationofpeakoxygenconsumption anaerobicthreshold ComponentsofIntegratedCPET Symptom limitedECGHRMeasureexpiredgasOxygenconsumptionCO2productionMinuteventilationSpO2orPO2PerceptualresponsesBreathlessnessLegdiscomfort ModifiedBorgCR 10Scale IndicationsforCPET EvaluationofdyspneaDistinguishcardiacvspulmonaryvsperipherallimitationvsotherDetectionofexercise inducedbronchoconstrictionDetectionofexertionaldesaturationPulmonaryrehabilitationExerciseintensity prescriptionResponsetoparticipationPre opevaluationandriskstratificationPrognosticationoflifeexpectancyDisabilitydeterminationFitnessevaluationDiagnosisAssessresponsetotherapy MortalityinCFPatients Nixonetal NEJM327 1785 1992 Followed109patientswithCFfor8yrsfromCPETPeakVO2 81 predicted 83 survivalPeakVO259 81 predicted 51 survivalPeakVO2 59 predicted 28 survival MortalityinCHFPatients Mancinietal Circulation83 778 1991 PeakVO2 14ml kg min 1 yrsurvival94 2 yrsurvival84 PeakVO2 14ml kg min 1 yrsurvival47 2 yrsurvival32 CPETtoPredictRiskofLungResectioninLungCancer Limetal Thorax65 iii1 2010Albertsetal Chest132 1s 2007Baladyetal Circulation122 191 2010PeakVO2 15ml kg minNosignificantincreasedriskofcomplicationsordeathPeakVO2 15ml kg minIncreasedriskofcomplicationsanddeathPeakVO2 10ml kg min40 50 mortalityConsidernon surgicalmanagement AbsoluteContraindicationstoCPET AcuteMIUnstableanginaUnstablearrhythmiaAcuteendocarditis myocarditis pericarditisSyncopeSevere symptomaticASUncontrolledCHFAcutePE DVTRespiratoryfailureUncontrolledasthmaSpO2 88 onRAAcutesignificantnon cardiopulmonarydisorderthatmayaffectorbeadverselyaffectedbyexerciseSignificantpsychiatric cognitiveimpairmentlimitingcooperation RelativeContraindicationstoCPET Leftmainor3 VCADSeverearterialHTN 200 120 SignificantpulmonaryHTNTachyarrhythmia bradyarrhythmiaHighdegreeAVblockHypertrophiccardiomyopathyElectrolyteabnormalityModeratestenoticvalvularheartdiseaseAdvancedorcomplicatedpregnancyOrthopedicimpairment IndicationsforEarlyExerciseTermination PatientrequestIschemicECGchanges2mmSTdepressionChestpainsuggestiveofischemiaSignificantectopy2ndor3rddegreeheartblockBpsys 240 250 Bpdias 110 120FallinBPsys 20mmHgSpO2 81 85 Dizziness faintnessOnsetconfusionOnsetpallor CPETMeasurements WorkVO2VCO2ATHRECGBP RSpO2ABGLactateCPDyspneaLegfatigue ExerciseModality AdvantagesofcycleergometerCheaperSaferLessdangeroffall injuryCanstopanytimeDirectpowercalculationIndependentofweightHoldingbarshasnoeffectLittletrainingneededEasierBPrecording blooddrawRequireslessspaceLessnoiseAdvantagesoftreadmillAttainhigherVO2Morefunctional IncrementalvsRampExerciseTestProtocol INCREMENTAL RAMP WORK TIME TIME WORK PhysiologyandChemistry SlowvsfasttwitchfibersBufferingoflacticacidbybicarbonateCO2productionfromcarbonicacidRespiratoryexchangeratioVentilatoryequivalentofoxygenVentilatoryequivalentofcarbondioxideGraphicaldeterminationofATFickEquationOxygenpulse PropertiesofSkeletalMuscleFibers Red Slowtwitch TypeISustainedactivityHighmitochondrialdensityMetabolizeglucoseaerobically1glucoseyields36ATPRapidrecovery White Fasttwitch TypeIIRapidburstexerciseFewmitochondriaMetabolizeglucoseanaerobically1glucoseyields2ATPand2lacticacidSlowrecovery LacticAcidisBufferedbyBicarbonate Lacticacid HCO3 H2CO3 Lactate H2O CO2 RespiratoryExchangeRatio RER CO2produced O2consumed VCO2 VO2 VentilatoryEquivalents Ventilatoryequivalentforcarbondioxide Minuteventilation VCO2EfficiencyofventilationLitersofventilationtoeliminate1LofCO2Ventilatoryequivalentforoxygen Minuteventilation VO2LitersofventilationperLofoxygenuptake RelationshipofATtoRERandVentilatoryEquivforO2 Belowtheanaerobicthreshold withcarbohydratemetabolism RER 1 CO2production O2consumption Abovetheanaerobicthreshold lacticacidisgenerated Lacticacidisbufferedbybicarbonatetoproducelactate water andcarbondioxide Abovetheanaerobicthreshold RER 1 CO2production O2consumption Carbondioxideregulatesventilation VentilationwilldisproportionatelyincreaseatlactatethresholdtoeliminateexcessCO2 Increaseinventilatoryequivalentforoxygendemarcatestheanaerobicthreshold LactateThreshold DeterminationofATfromRERPlot VSlopeMethod DeterminationofATfromVentilatoryEquivalentPlot Wasserman9 PanelPlot OxygenConsumption FickEquation FickEquation Q VO2 C a v O2VO2 QxC a v O2VO2 SVxHRxC a v O2 Heartdisease HeartdiseaseLungdiseaseMusclediseaseDeconditioning AnemiaLungdisease lowSaO2 Arterialoxygencontent 1 34 SaO2 Hgb Venousoxygencontent 1 34 SvO2 Hgb OxygenPulse OxygenPulse theamountofoxygenconsumedbythebodyfromthebloodofonesystolicdischargeoftheheart HendersonandPrinceAmJPhysiol35 106 1914OxygenPulse VO2 HRFickEquation VO2 SVxHRxC a v O2VO2 HR SVxC a v O2OxygenPulse SV InterpretationofCPET PeakoxygenconsumptionPeakHRPeakworkPeakventilationAnaerobicthresholdHeartratereserveBreathingreserve HeartRateReserve ComparisonofactualpeakHRandpredictedpeakHR 1 Actual Predicted x100 Normal 15 EstimationofPredictedPeakHR 220 ageForage40 220 40 180Forage70 220 70 150210 agex0 65 Forage40 210 40 x0 65 184Forage70 210 70 x0 65 164 BreathingReserve ComparisonofactualpeakventilationandpredictedpeakventilationPredictedpeakventilation MVV orFEV1x35 1 Actual Predicted x100 Normal 30 ComparisonCPETresults NormalCHFCOPDPredictedPeakHR150150150PeakHR150140120MVV10010050PeakVO22 01 21 2AT1 00 61 0PeakVE604049BreathingReserve40 60 2 HRReserve0 7 20 BorgBreathlessness548BorgLegDiscomfort885 CardiacvsPulmonaryLimitation HeartDiseaseBreathingreserve 30 Heartratereserve15 CPETInterpretation PeakVO2HRRBRAT VO2maxA aNormal 80 30 40 normalHeartdisease30 30 15 40 increasedDeconditioning15 30 40 normal SUMMARY Cardiopulmonarymeasurementsobtainedatrestmaynotestimatefunctionalcapacityreliably CPETincludesthemeasurementofexpiredoxygenandcarbondioxide TheBorgscaleisavalidatedinstrumentformeasurementofperceptualresponses CPETmayassistinpre
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025至2030中國自動(dòng)駕駛潛艇行業(yè)發(fā)展趨勢分析與未來投資戰(zhàn)略咨詢研究報(bào)告
- 2025至2030中國自動(dòng)柜員機(jī)外包行業(yè)產(chǎn)業(yè)運(yùn)行態(tài)勢及投資規(guī)劃深度研究報(bào)告
- 2025至2030中國膝蓋重建材料行業(yè)產(chǎn)業(yè)運(yùn)行態(tài)勢及投資規(guī)劃深度研究報(bào)告
- 2025至2030中國胰島素樣生長因子1受體行業(yè)產(chǎn)業(yè)運(yùn)行態(tài)勢及投資規(guī)劃深度研究報(bào)告
- 2025至2030中國腫瘤標(biāo)記物測試行業(yè)產(chǎn)業(yè)運(yùn)行態(tài)勢及投資規(guī)劃深度研究報(bào)告
- 2025至2030中國肌松藥行業(yè)深度研究及發(fā)展前景投資評(píng)估分析
- 2025至2030中國聯(lián)合辦學(xué)行業(yè)深度研究及發(fā)展前景投資評(píng)估分析
- 2025至2030中國網(wǎng)球握拍過度行業(yè)產(chǎn)業(yè)運(yùn)行態(tài)勢及投資規(guī)劃深度研究報(bào)告
- 2025至2030中國綠色蔬菜生產(chǎn)行業(yè)市場深度調(diào)研及發(fā)展策略與投資前景預(yù)測報(bào)告
- 2025至2030中國結(jié)晶芳香聚酯行業(yè)產(chǎn)業(yè)運(yùn)行態(tài)勢及投資規(guī)劃深度研究報(bào)告
- GB/T 1874-1995磷礦石和磷精礦中酸不溶物含量的測定重量法
- GB 30980-2014海洋傾倒物質(zhì)評(píng)價(jià)規(guī)范疏浚物
- GA/T 1169-2014警用電子封控設(shè)備技術(shù)規(guī)范
- 第十二篇 糖尿病患者生活常識(shí)
- 污水處理站安全培訓(xùn)課件
- 2015高考全國新課標(biāo)1地理試題及答案
- 超星爾雅《詩經(jīng)》導(dǎo)讀檢測題答案
- GB 27954-2020 黏膜消毒劑通用要求
- 中考《紅星照耀中國》各篇章練習(xí)題及答案(1-12)
- (完整版)ECRS培訓(xùn)課件
- 外輪理貨工作英語
評(píng)論
0/150
提交評(píng)論